Evidence map›Paper›PMID 31482412›Full record

ReviewMolecular imaging and biology2020

Clinical Applications for Radiotracer Imaging of Lower Extremity Peripheral Arterial Disease and Critical Limb Ischemia.

Ting-Heng Chou, Mitchel R Stacy

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Molecular imaging and biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03622359 (Radiotracer Imaging of Skeletal Muscle Perfusion in Patients With Peripheral Artery Disease), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03622359 narecruitingnot on this map

Radiotracer Imaging of Skeletal Muscle Perfusion in Patients With Peripheral Artery Disease

TypeinterventionalSponsorNationwide Children's HospitalRan2017 to 2028Enrolled192ConditionsPeripheral Artery Disease, Diabetes Mellitus, Chronic Limb-Threatening IschemiaArmsSPECT/CT perfusion imaging, PET/CT perfusion imaging
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Prognostic value of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Feasibility of [Frontiers in nuclear medicine · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Novel Application ofFrontiers in medicine · 2022
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ting-Heng ChouCenter for Regenerative Medicine, The Research Institute at Nationwide Children's Hospital, 575 Children's Crossroad, WB4131, Columbus, OH, 43215, USA.
Mitchel R StacyCenter for Regenerative Medicine, The Research Institute at Nationwide Children's Hospital, 575 Children's Crossroad, WB4131, Columbus, OH, 43215, USA. mitchel.stacy@nationwidechildrens.org.ORCID 0000-0002-8423-1011
Nationwide Children's Hospital · US

Funding

Radiotracer-Based Imaging for Quantitative Assessment of Skeletal Muscle Perfusion in Peripheral Artery DiseaseR01HL135103 · NHLBI · YALE UNIVERSITY · PI Mitchel R Stacy · 2017 to 2026
$3.8M
NHLBI NIH HHS R01 HL135103
6 · The paper itself

Abstract

Peripheral arterial disease (PAD) is an atherosclerotic occlusive disease of the non-coronary vessels that is characterized by lower extremity tissue ischemia, claudication, increased prevalence of lower extremity wounds and amputations, and impaired quality of life. Critical limb ischemia (CLI) represents the severe stage of PAD and is associated with additional risk for wound formation, amputation, and premature death. Standard clinical tools utilized for assessing PAD and CLI primarily focus on anatomical evaluation of peripheral vascular lesions or hemodynamic assessment of the peripheral circulation. Evaluation of underlying pathophysiology has traditionally been achieved by radiotracer-based imaging, with many clinical investigations focusing on imaging of skeletal muscle perfusion and cases of foot infection/inflammation such as osteomyelitis and Charcot neuropathic osteoarthropathy. As advancements in hybrid imaging systems and radiotracers continue to evolve, opportunities for molecular imaging of PAD and CLI are also emerging that may offer novel insight into associated complications such as peripheral atherosclerosis, alterations in skeletal muscle metabolism, and peripheral neuropathy. This review summarizes the pros and cons of radiotracer-based techniques that have been utilized in the clinical environment for evaluating lower extremity ischemia and common pathologies associated with PAD and CLI.

Indexed as

RadiopharmaceuticalsFootHumansInflammationIschemiaMuscle, SkeletalOrganophosphorus CompoundsOrganotechnetium CompoundsOsteomyelitisPerfusionPeripheral Arterial DiseasePositron Emission Tomography Computed TomographySingle Photon Emission Computed Tomography Computed TomographyOrganophosphorus CompoundsOrganotechnetium CompoundsRadiopharmaceuticalstechnetium tc-99m tetrofosminCritical limb ischemiaPeripheral arterial diseasePositron emission tomographyRadiotracer imagingSingle-photon emission computed tomography

Identifiers

PMID31482412
PMCPMC7580768
OpenAlexW2971586989

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.